Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.

<h4>Background</h4>Endometrial cancer is the most common gynecologic malignancy in developed countries and little is known about the underlying mechanism of stage and disease outcomes. The goal of this study was to identify differentially expressed genes (DEG) between late vs. early stag...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paulette Mhawech-Fauceglia, Dan Wang, Joshua Kesterson, Kimberly Clark, Laketa Monhollen, Kunle Odunsi, Shashikant Lele, Song Liu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/86ebbe01b80b4addb6f0a56078f1cbe0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:86ebbe01b80b4addb6f0a56078f1cbe0
record_format dspace
spelling oai:doaj.org-article:86ebbe01b80b4addb6f0a56078f1cbe02021-11-18T07:02:23ZMicroarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.1932-620310.1371/journal.pone.0015415.s001https://doaj.org/article/86ebbe01b80b4addb6f0a56078f1cbe02010-11-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21079744/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Endometrial cancer is the most common gynecologic malignancy in developed countries and little is known about the underlying mechanism of stage and disease outcomes. The goal of this study was to identify differentially expressed genes (DEG) between late vs. early stage endometrioid adenocarcinoma (EAC) and uterine serous carcinoma (USC), as well as between disease outcomes in each of the two histological subtypes.<h4>Methodology/principal finding</h4>Gene expression profiles of 20 cancer samples were analyzed (EAC = 10, USC = 10) using the human genome wide illumina bead microarrays. There was little overlap in the DEG sets between late vs. early stages in EAC and USC, and there was an insignificant overlap in DEG sets between good and poor prognosis in EAC and USC. Remarkably, there was no overlap between the stage-derived DEGs and the prognosis-derived DEGs for each of the two histological subtypes. Further functional annotation of differentially expressed genes showed that the composition of enriched function terms were different among different DEG sets. Gene expression differences for selected genes of various stages and outcomes were confirmed by qRT-PCR with a high validation rate.<h4>Conclusion</h4>This data, although preliminary, suggests that there might be involvement of distinct groups of genes in tumor progression (late vs. early stage) in each of the EAC and USC. It also suggests that these genes are different from those involved in tumor outcome (good vs. poor prognosis). These involved genes, once clinically verified, may be important for predicting tumor progression and tumor outcome.Paulette Mhawech-FaucegliaDan WangJoshua KestersonKimberly ClarkLaketa MonhollenKunle OdunsiShashikant LeleSong LiuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 11, p e15415 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Paulette Mhawech-Fauceglia
Dan Wang
Joshua Kesterson
Kimberly Clark
Laketa Monhollen
Kunle Odunsi
Shashikant Lele
Song Liu
Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
description <h4>Background</h4>Endometrial cancer is the most common gynecologic malignancy in developed countries and little is known about the underlying mechanism of stage and disease outcomes. The goal of this study was to identify differentially expressed genes (DEG) between late vs. early stage endometrioid adenocarcinoma (EAC) and uterine serous carcinoma (USC), as well as between disease outcomes in each of the two histological subtypes.<h4>Methodology/principal finding</h4>Gene expression profiles of 20 cancer samples were analyzed (EAC = 10, USC = 10) using the human genome wide illumina bead microarrays. There was little overlap in the DEG sets between late vs. early stages in EAC and USC, and there was an insignificant overlap in DEG sets between good and poor prognosis in EAC and USC. Remarkably, there was no overlap between the stage-derived DEGs and the prognosis-derived DEGs for each of the two histological subtypes. Further functional annotation of differentially expressed genes showed that the composition of enriched function terms were different among different DEG sets. Gene expression differences for selected genes of various stages and outcomes were confirmed by qRT-PCR with a high validation rate.<h4>Conclusion</h4>This data, although preliminary, suggests that there might be involvement of distinct groups of genes in tumor progression (late vs. early stage) in each of the EAC and USC. It also suggests that these genes are different from those involved in tumor outcome (good vs. poor prognosis). These involved genes, once clinically verified, may be important for predicting tumor progression and tumor outcome.
format article
author Paulette Mhawech-Fauceglia
Dan Wang
Joshua Kesterson
Kimberly Clark
Laketa Monhollen
Kunle Odunsi
Shashikant Lele
Song Liu
author_facet Paulette Mhawech-Fauceglia
Dan Wang
Joshua Kesterson
Kimberly Clark
Laketa Monhollen
Kunle Odunsi
Shashikant Lele
Song Liu
author_sort Paulette Mhawech-Fauceglia
title Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
title_short Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
title_full Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
title_fullStr Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
title_full_unstemmed Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
title_sort microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/86ebbe01b80b4addb6f0a56078f1cbe0
work_keys_str_mv AT paulettemhawechfauceglia microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT danwang microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT joshuakesterson microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT kimberlyclark microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT laketamonhollen microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT kunleodunsi microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT shashikantlele microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
AT songliu microarrayanalysisrevealsdistinctgeneexpressionprofilesamongdifferenttumorhistologystageanddiseaseoutcomesinendometrialadenocarcinoma
_version_ 1718424054138929152